Lobbying Relationship

Client

Pfizer Inc.

More records

Lobbying firm

PATTON BOGGS LLP

More records

  • P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 P.L. 111-5, American Recovery and Reinvestment Act H.R. 4899, FY 2010 Supplemental Appropriations Act

Duration: to

General Issues: Health Issues, Medicare/Medicaid, Labor Issues/Antitrust/Workplace

Spending: about $600,000 (But it's complicated. Here's why.)

Agencies lobbied since 2008: House of Representatives, U.S. Senate

Bills mentioned

H.R.4899: Supplemental Appropriations Act, 2010

Sponsor: David R. Obey (D-Wis.)

H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...

Sponsor: John D. Dingell (D-Mich.)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4872: Health Care and Education Reconciliation Act of 2010

Sponsor: John M. Spratt Jr. (D-S.C.)

S.1796: America's Healthy Future Act of 2009

Sponsor: Max Baucus (D-Mont.)

H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

S.726: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Charles E. Schumer (D-N.Y.)

H.R.1548: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

S.1213: Patient-Centered Outcomes Research Act of 2009

Sponsor: Max Baucus (D-Mont.)

H.R.2502: Comparative Effectiveness Research Act of 2009

Sponsor: Kurt Schrader (D-Ore.)

H.R.2824: Doctor-Patient Relationship and Research Protection Act

Sponsor: Donna M.C. Christensen (D-Virgin Islands)

H.R.1706: Protecting Consumer Access to Generic Drugs Act of 2009

Sponsor: Bobby L. Rush (D-Ill.)

H.R.759: Food and Drug Administration Globalization Act of 2009

Sponsor: John D. Dingell (D-Mich.)

S.882: Drug and Device Accountability Act of 2009

Sponsor: Edward M. Kennedy (D-Mass.)

H.R.1298: Pharmaceutical Market Access and Drug Safety Act of 2009

Sponsor: Marion Berry (D-Ark.)

S.1232: Pharmaceutical Market Access and Drug Safety Act of 2009

Sponsor: Byron L. Dorgan (D-N.D.)

S.333: A bill to amend the Internal Revenue Code of 1986 to allow an...

Sponsor: Barbara A. Mikulski (D-Md.)

H.R.684: Medicare Prescription Drug Savings and Choice Act of 2009

Sponsor: Marion Berry (D-Ark.)

H.R.904: Medicaid Prescription Drug Rebate Equalization Act of 2009

Sponsor: Bart Stupak (D-Mich.)

S.547: Drug Rebate Equalization Act of 2009

Sponsor: Jeff Bingaman (D-N.M.)

H.R.1725: Voluntary State Discount Prescription Drug Plan Act of 2009

Sponsor: Chris Van Hollen (D-Md.)

S.1693: Wired for Health Care Quality Act

Sponsor: Edward M. Kennedy (D-Mass.)

H.R.3162: Children's Health and Medicare Protection Act of 2007

Sponsor: John D. Dingell (D-Mich.)

H.R.6331: Medicare Improvements for Patients and Providers Act of 2008

Sponsor: Charles B. Rangel (D-N.Y.)

S.3101: Medicare Improvements for Patients and Providers Act of 2008

Sponsor: Max Baucus (D-Mont.)

S.3118: Preserving Access to Medicare Act of 2008

Sponsor: Charles E. Grassley (R-Iowa)

H.R.6357: PRO(TECH)T Act of 2008

Sponsor: John D. Dingell (D-Mich.)

H.R.1283: Arthritis Prevention, Control, and Cure Act of 2008

Sponsor: Anna G. Eshoo (D-Calif.)

S.2999: Access to Cancer Clinical Trials Act of 2008

Sponsor: Sherrod Brown (D-Ohio)

H.R.6311: Nonnative Wildlife Invasion Prevention Act

Sponsor: Madeleine Z. Bordallo (D-Guam)

H.R.2994: National Pain Care Policy Act of 2008

Sponsor: Lois Capps (D-Calif.)

S.2499: Medicare, Medicaid, and SCHIP Extension Act of 2007

Sponsor: Max Baucus (D-Mont.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Eric Rasmussen SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000
Jonathan Yarowsky GCHouseJudCom82-95; SACPres95-98
John Jonas n/a
Todd Tuten n/a
Sara van Geertruyden n/a
Stuart Pape n/a
Kathleen Lester n/a
Karen Thiel n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page